Applied Financial Statements From 2010 to 2026

BNBX Stock   1.48  0.25  20.33%   
Applied DNA's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Applied DNA's valuation are provided below:
We have found one hundred sixteen available fundamental signals for Applied DNA Sciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Applied DNA Sciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 387.8 K in 2026, whereas Enterprise Value is likely to drop (5 M) in 2026.

Applied DNA Total Revenue

1.83 Million

Check Applied DNA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied DNA's main balance sheet or income statement drivers, such as Net Interest Income of 232.9 K, Interest Income of 232.9 K or Depreciation And Amortization of 838.7 K, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.0424. Applied financial statements analysis is a perfect complement when working with Applied DNA Valuation or Volatility modules.
  
Build AI portfolio with Applied Stock
Check out the analysis of Applied DNA Correlation against competitors.

Applied DNA Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.8 MM12.9 M
Slightly volatile
Other Current Liabilities936.9 K564.9 K977.8 K
Pretty Stable
Total Current Liabilities2.4 M2.2 M3.1 M
Slightly volatile
Total Stockholder EquityM2.1 M9.2 M
Slightly volatile
Property Plant And Equipment Net372.8 K392.4 K2.4 M
Slightly volatile
Current Deferred Revenue50.3 K52.9 K232.5 K
Slightly volatile
Accounts Payable1.1 M760.3 K1.7 M
Slightly volatile
Cash1.4 M1.5 M6.2 M
Slightly volatile
Non Current Assets Total3.9 M2.5 M3.3 M
Pretty Stable
Non Currrent Assets Other537.7 K862.5 K282 K
Slightly volatile
Cash And Short Term Investments7.1 M5.8 M7.1 M
Pretty Stable
Net Receivables203 K213.7 K2.1 M
Slightly volatile
Common Stock Shares OutstandingM1.9 M336 K
Slightly volatile
Liabilities And Stockholders Equity12.6 M11.5 M14.4 M
Pretty Stable
Non Current Liabilities Total27.2 K28.7 K762.4 K
Slightly volatile
Inventory71.9 K75.7 K980.7 K
Slightly volatile
Other Current Assets207 K217.9 K540.5 K
Slightly volatile
Other Stockholder Equity337.4 M366.6 M306 M
Slightly volatile
Total Liabilities4.4 M2.2 MM
Pretty Stable
Net Invested CapitalM2.1 M9.2 M
Slightly volatile
Property Plant And Equipment GrossM4.3 M4.1 M
Slightly volatile
Total Current Assets1.9 MM9.8 M
Slightly volatile
Capital Stock1.4 K1.5 K6.5 K
Slightly volatile
Common Stock6.3 K9.3 K7.8 K
Pretty Stable
Short and Long Term Debt Total790.8 K665.2 K1.1 M
Slightly volatile
Short Term Debt574.5 K627.8 K516.2 K
Slightly volatile
Intangible Assets2.2 M2.4 M2.7 M
Slightly volatile

Applied DNA Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income232.9 K221.9 K62.2 K
Slightly volatile
Interest Income232.9 K221.9 K62.2 K
Slightly volatile
Depreciation And Amortization838.7 K626.8 K870.6 K
Very volatile
Selling General Administrative10.1 M9.8 M12.4 M
Slightly volatile
Total Revenue1.8 M1.9 M8.2 M
Slightly volatile
Gross Profit717.3 K755 K3.7 M
Slightly volatile
Other Operating Expenses19.3 M15.7 M21.9 M
Slightly volatile
Research Development4.7 M6.9 M4.4 M
Slightly volatile
Cost Of Revenue1.1 M1.2 M4.5 M
Pretty Stable
Total Operating Expenses13.9 M16.4 M17.4 M
Slightly volatile
Reconciled Depreciation328.5 K345.7 K805.7 K
Slightly volatile

Applied DNA Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation87.2 K91.8 K1.3 M
Slightly volatile
Begin Period Cash Flow9.8 M8.3 M8.3 M
Slightly volatile
Depreciation328.5 K345.7 K805.7 K
Slightly volatile
Capital Expenditures267.7 K281.8 K1.8 M
Slightly volatile
End Period Cash Flow2.1 M2.2 M6.4 M
Pretty Stable
Other Non Cash Items927.4 K585.3 K1.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.110.11960.0275
Slightly volatile
PTB Ratio0.04240.04040.0111
Slightly volatile
Days Sales Outstanding60.6344.2888.0939
Slightly volatile
Book Value Per Share92.6497.5215.3 K
Slightly volatile
Average Payables1.5 M1.7 M1.8 M
Slightly volatile
PB Ratio0.04240.04040.0111
Slightly volatile
Inventory Turnover4.714.956.0399
Slightly volatile
Days Of Inventory On Hand57.3276.2588.7374
Slightly volatile
Payables Turnover2.262.382.8515
Pretty Stable
Average Inventory673.4 K442 K834.3 K
Slightly volatile
Research And Ddevelopement To Revenue0.990.940.5644
Slightly volatile
Cash Per Share66.4369.939.6 K
Slightly volatile
Days Payables Outstanding87.23159145
Slightly volatile
Intangibles To Total Assets0.160.190.1966
Pretty Stable
Net Debt To EBITDA0.770.490.5943
Pretty Stable
Current Ratio3.973.863.5377
Pretty Stable
Tangible Book Value Per Share64.7668.1715.3 K
Slightly volatile
Receivables Turnover14.188.537.9602
Slightly volatile
Shareholders Equity Per Share94.4499.4115.3 K
Slightly volatile
Debt To Equity0.08830.0930.2113
Slightly volatile
Average Receivables337.3 K355.1 K2.2 M
Slightly volatile
Revenue Per Share35.4537.3113 K
Slightly volatile
Interest Debt Per Share7.648.0456.0395
Slightly volatile
Debt To Assets0.08160.06650.0848
Slightly volatile
Enterprise Value Over EBITDA0.760.460.5878
Very volatile
Operating Cycle118121177
Slightly volatile
Price Book Value Ratio0.04240.04040.0111
Slightly volatile
Price Earnings To Growth Ratio6.0E-46.0E-42.0E-4
Slightly volatile
Days Of Payables Outstanding87.23159145
Slightly volatile
Ebt Per Ebit0.850.580.9244
Slightly volatile
Company Equity Multiplier1.431.261.4258
Slightly volatile
Total Debt To Capitalization0.150.0860.1756
Slightly volatile
Debt Equity Ratio0.08830.0930.2113
Slightly volatile
Quick Ratio3.733.653.2035
Slightly volatile
Net Income Per E B T1.091.131.0113
Slightly volatile
Cash Ratio2.172.412.2428
Slightly volatile
Days Of Inventory Outstanding57.3276.2588.7374
Slightly volatile
Days Of Sales Outstanding60.6344.2888.0939
Slightly volatile
Price To Book Ratio0.04240.04040.0111
Slightly volatile
Fixed Asset Turnover5.573.053.6107
Slightly volatile
Enterprise Value Multiple0.760.460.5878
Very volatile
Debt Ratio0.08160.06650.0848
Slightly volatile
Price Sales Ratio0.110.11960.0275
Slightly volatile
Asset Turnover0.290.310.5776
Slightly volatile
Gross Profit Margin0.410.340.441
Slightly volatile
Price Fair Value0.04240.04040.0111
Slightly volatile

Applied DNA Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap387.8 K369.3 K98.2 K
Slightly volatile

About Applied DNA Financial Statements

Applied DNA investors use historical fundamental indicators, such as Applied DNA's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Applied DNA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue52.9 K50.3 K
Total Revenue1.9 M1.8 M
Cost Of Revenue1.2 M1.1 M
Research And Ddevelopement To Revenue 0.94  0.99 
Revenue Per Share 37.31  35.45 
Ebit Per Revenue(4.70)(4.47)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Applied Stock Analysis

When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.